|
Match
|
Document |
Document Title |
|
|
US20110015264 |
INTRAMUSCULAR ANTIVIRAL TREATMENTS
The invention provides unit dosage forms, kits, and methods useful for treating viral infections.
|
|
|
US20110212170 |
Formulation For Retinoid-Containing Soft Gelatin Capsules
A new pharmaceutical formulation for retinoid-containing soft gelatin capsules is disclosed. The new formulation comprises a soft gelatin capsule filled with a fill mass comprising a retinoid as an...
|
|
|
US20120093738 |
TASTE-MASKED ORAL FORMULATIONS OF INFLUENZA ANTIVIRALS
The present invention relates to taste-masked oral formulations of influenza antivirals. The taste-masked pharmaceutical formulations for oral administration comprise one or more influenza...
|
|
|
US20110244051 |
PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF OVERACTIVE BLADDER
Disclosed herein are pharmaceutical compositions comprising a plurality of first beads each comprising: a core; a first layer comprising pilocarpine or a pharmaceutically acceptable salt thereof;...
|
|
|
US20110028510 |
Compositions, Methods, and Kits for Treating Influenza Viral Infections
The present invention provides compositions, methods, and kits for treating or preventing a viral infection (e.g., an infection caused by an influenza virus).
|
|
|
US20110218143 |
COMPOSITIONS AND METHODS FOR TISSUE REPAIR
The invention generally provides compositions and methods for the repair or regeneration of a tissue or organ in need thereof.
|
|
|
US20110281853 |
COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ATRIAL FIBRILLATION
The present invention provides compositions and methods for treating or preventing atrial fibrillation (AF). In particular, the present invention provides administration of muscarinic receptor...
|
|
|
US20110092582 |
New Terpenes And Macrocycles
Novel terpenes and macrocycles are activators of TGR5 and can be used for the prevention and/or treatment of Diabetes Type 2, obesity, neuropathy and/or nephropathy.
|
|
|
US20110059920 |
AGENT FOR REGENERATION AND/OR PROTECTION OF NERVES
An EP2 agonist which may have an EP3 agonistic effect has an effect of regenerating and/or protecting nerves, and is therefore useful as a therapeutic agent for a disease of the peripheral nervous...
|
|
|
US20120046276 |
Tuberculosis treatment using pleuromutilin derivatives
A method of preventing or treating diseases caused by Mycobacterium, comprising administering to a subject in need of such treatment an effective amount of a pleuromutilin.
|
|
|
US20110094914 |
LONG-WEAR MASCARA COMPOSITIONS
A cosmetic composition for use on eyelashes and/or eyelids that includes from about 15% to about 50%, by weight, of a film former selected from the group consisting of tall oil glyceride,...
|
|
|
US20090105336 |
Beneficial Effects of Increasing Local Blood Flow
The present invention provides a treatment for enhancing the ability of the body to heal wounds. A topical cream is described which improves blood flow by the transdermal delivery of the nitric...
|
|
|
US20120129929 |
COMPOUND USED TO PREVENT DISEASES CAUSED BY AQUAPORIN DEFICIENCY
A compound used to prevent diseases caused by aquaporin deficiency, which is 18β-Glycyrrhetinic acid derivative. Said compound can not only prevent diseases caused aquaporin deficiency, but be ...
|
|
|
US20100099565 |
STORAGE-STABLE COMPOSITIONS CONTAINING HYDROGEN CYANAMIDE AND PROPIONIC ACID
An aqueous storage-stable composition comprises from about 10 to about 35% by weight hydrogen cyanamide, from about 3 to about 25% by weight propionic acid, potassium propionate or ammonium...
|
|
|
US20090176877 |
OSELTAMIVIR PHOSHATE GRANULE AND PREPARATION METHOD THEREOF
The present invention relates to an oseltamivir phosphate granule and preparation method thereof. The said granule comprises 1.97-19.8 wt. % oseltamivir phosphate, 75.0-97.5 wt. % diluent, 0.1-5.0...
|
|
|
US20080269326 |
Use of 1-Phenyl-3-Dimethylamino-propane Compounds for Treating Neuropathic Pain
Use of 1-phenyl-3-dimethylaminopropane compounds for the production of medicaments for treating neuropathic pain, preferably polyneuropathic pain, also preferably diabetic neuropathic pain, more...
|
|
|
US20110082203 |
PROCESS TO DIAGNOSE OR TREAT BRAIN INJURY
A process for diagnosing and treating a neurological condition in a subject is provided that includes assaying a biological sample of a subject for the presence of one or more biomarkers;...
|
|
|
US20060211766 |
Gelled immunomodulating topical compositions and a method of treating warts and other human papilloma virus skin infections
Topical drug compositions of this invention contain delayed type contact sensitizing haptens in a unique non-flowable, non-toxic, non-volatile, anhydrous gel composition to achieve retained site...
|
|
|
US20110257255 |
COMPOSITION AND METHOD FOR INHIBITION OF NERVE TRANSMISSION
The presently claimed and disclosed invention(s) provides a therapeutically effective composition and method of inhibiting nerve cell transmission. In a preferred embodiment of the presently...
|
|
|
US20050209319 |
Treatment of local pain
Methods and compositions for treating or preventing local pain or discomfort, particularly local neuropathic pain via topical application directly to skin or mucosal tissue at the site of pain or...
|
|
|
US20110124725 |
Treatment for Meibomian Gland Dysfunction or Obstruction
A jojoba formulation has been developed for administration to the meibomian gland, for treatment of the symptoms of dry eye, and/or for drug delivery to the meibomian gland. The formulation...
|
|
|
US20110206626 |
Method for Treating Skin with Booster Compositions
A skin care product comprising from about 0.001% to about 10% of a retinoid, in combination with 0.0001% to about 50% of a combination of retinoid boosters.
|
|
|
US20080312320 |
Non-dusty, free flowing, storage stable solid composition and a process for its preparation
A solid water dispersible granular composition of pesticide comprising up to 50% of at least one pesticide from pyrethroid class, more particularly a highly viscous liquid pyrethroid insecticide,...
|
|
|
US20120128754 |
TREATMENT OF EYE DISCOMFORT BY TOPICAL ADMINISTRATION OF A COOLING AGENT TO THE EXTERNAL SURFACE OF THE EYELID
The present invention pertains generally to the field of ocular treatment, and more specifically to the use of a liquid cooling agent composition comprising a cooling agent for the treatment of...
|
|
|
US20080176921 |
AUXIN ACID-CATALYZED STABLE MICROEMULSION PESTICIDE FORMULATION
An auxin acid-catalyzed stable microemulsion pesticide formulation is provided that is clear and stable under a wide range of temperature conditions encountered during distribution, storage, and...
|
|
|
US20080199458 |
INFLUENZA PREVENTION AND TREATMENT COMPOSITION
A composition for influenza treatment includes an immune enhancer and an anti-viral agent
|
|
|
US20110129530 |
Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture
There is provided a method for preparing a pharmaceutical composition comprising compressible coated, taste-masked and/or controlled-release coated drug-containing particles, rapidly-dispersing...
|
|
|
US20110014257 |
BIODEGREADABLE DEVICE WITH SLOW-RELEASE OF VOLATILE PRODUCTS HAVING AN ATTRACTANT ACTION FOR THE CONTROL OF INSECTS
The invention describes a biodegradable device with a slow-release of volatile products having an attractant action with respect to insects, which can be applied to a wide range of crops.
|
|
|
US20080319064 |
DEUTERIUM-ENRICHED OSELTAMIVIR
The present application describes deuterium-enriched oseltamivir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
|
|
|
US20090060881 |
Gamma secretase inhibitor for treatment of herpesvirus infection
This invention relates to methods and compositions for the treatment of malignancies associated with gamma-herpesvirus infection. Specifically, the invention relates to the use of gamma-secretase...
|
|
|
US20120029072 |
PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES
Disclosed are pleuromutilin derivatives of formula (I) an their use in the treatment of diseases mediated by microbes.
|
|
|
US20090098173 |
TOPICAL PAIN RELIEF PRODUCT
The present invention is directed to a topical composition comprising a counterirritant active ingredient and a sensate that provides a cooling sensation to the skin that is topically perceptible...
|
|
|
US20090275539 |
Nuclear Transcription Factors Regulators
The present invention relates to novel compounds that are nuclear transcription factors (NTF) regulators. The present invention also provides methods for treating, preventing and/or reducing...
|
|
|
US20110077298 |
Retinoid Derivative and Pharmaceutical Composition and Use Thereof
The invention relates to a retinoid derivative and pharmaceutical composition and use thereof. The compound of the invention is capable of preventing or treating hematological tumours, such as...
|
|
|
US20110142769 |
LOW TOXICITY TOPICAL ACTIVE AGENT DELIVERY SYSTEM
An active agent delivery composition is provided that allows topical delivery of active agents including vitamin A and its derivatives. A polyhalogenic vehicle such as methoxyonafluorobutane or...
|
|
|
US20100203084 |
METHOD FOR TREATING PAIN OR OPIOID DEPENDENCE USING A SPECIFIC TYPE OF NON-OPIOID AGENT IN COMBINATION WITH A SELECTIVE EXCITATORY-OPIOID-RECEPTOR INACTIVATOR
The present invention provides a method for treating pain in a subject in need of treatment, by administering to the subject a non-opioid agent in combination with a selective...
|
|
|
US20120071547 |
COMPOUNDS FROM SOFT CORAL, METHOD OF PREPARATION AND PHARMACEUTICAL USES THEREOF
The invention relates to compounds from the soft coral and the generation thereof. The invention also relates to the uses of the compounds from the soft coral in inhibiting inducible nitric oxide...
|
|
|
US20090131519 |
Use of Growth Regulators for Reducing or Preventing the Contamination of Plants and Vegetable Products by Trichothecene-Producing Mould Toxins
The present invention relates to the use of growth regulators selected from acylcyclohexanedione derivatives and quaternary ammonium compounds for reducing or preventing the contamination of plants...
|
|
|
US20080200549 |
PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND PARACETAMOL AND METHODS OF USING THE SAME
A combination pharmaceutical composition for the treatment of pain comprising between about 125 mg and about 150 mg ibuprofen and between about 475 mg and about 500 mg paracetamol, and a method for...
|
|
|
US20100184855 |
Hard Surface Cleaner Compositions of Sulfonated Estolides and Other Derivatives of Fatty Acids and Uses Thereof
Sulfo-estolides and formulations of sulfo-estolides in and as hard surface cleaners, glass cleaners, toilet bowl cleaners, carpet cleaners, all purpose cleaners, floor cleaners, and others are...
|
|
|
US20100016381 |
STABLE EMULSION COMPOSITION
The present invention provides an emulsion composition comprising (A) a compound stable in an acidic range, and (B) a buffer, wherein the pH is adjusted from about 3.7 to about 5.5.
|
|
|
US20090191144 |
USE OF LIPID COMPONENTS AGAINST POLLEN ALLERGIES
A cosmetic or dermatological preparation for combating or substantially preventing pollen allergies. The preparation comprises or essentially consists of a lipid phase which comprises one or more...
|
|
|
US20070292464 |
FIBERS AND SHEET-FORM TEXTILES PROVIDED WITH INSECT-REPELLENT FINISHES
The present invention relates to fibers and sheet-form textiles which are characterized in that they are finished with mixtures of (a) microencapsulated insect repellents and (b) binders.
|
|
|
US20070185193 |
Huvastatin and its preparation and formulation comprising the huvastatin
The invention relates to statin compounds, and it discloses novel small molecule compounds, i.e., huvastatins, which are classified into I, II, and III. The invention also provides the preparation...
|
|
|
US20080063710 |
Rapidly Disintegrating Tablet and Production Method Thereof
To provide a production method of a rapidly disintegrating tablet, the method that has versatility and, without a specialized device, can efficiently produce rapidly disintegrating tablets having a...
|
|
|
US20070042056 |
Anti-stress agent
The present invention provides an anti-stress agent which can effectively prevent or alleviate various symptoms caused by stress and which is safe and easily taken or ingested. The anti-stress...
|
|
|
US20090175807 |
PEST CONTROL, COMPOSITIONS, AND METHODS AND PRODUCTS UTILIZING SAME
Pest-combating compositions containing modified volatility pest-control actives are formulated for sustained test-combating efficacy, utilizing oleochemicals subjected to transesterification,...
|
|
|
US20090325919 |
METHOD OF PREPARATION OF A SOLUBLE FORMULATION OF WATER-INSOLUBLE PENTACYCLIC AND TETRACYCLIC TERPENOIDS, A SOLUBLE FORMULATION OF A PENTACYCLIC OR TETRACYCLIC TERPENOID AND A PHARMACEUTICAL COMPOSITION CONTAINING THIS SOLUBLE FORMULATION
The invention relates to a method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, wherein the water-insoluble terpenoid having a free carboxylic,...
|
|
|
US20100222427 |
PHARMACEUTICAL COMPOSITION COMPRISING OSELTAMIVIR PHOSPHATE
The present invention provides a pharmaceutical composition comprising: one or more excipients selected from sugars and sugar alcohols in which equilibrium water content is 1% by weight or less at...
|
|
|
US20120053152 |
(R)-(-)-1,2-propanediol compositions and methods
Short-chain 2- to 3-carbon alcohols are used as solvents for cooling agents in the preparation of topical therapeutic and cosmetic formulations. Some of these alcohols, especially ethanol, inhibit...
|